基于机器学习的高尿酸血症患者痛风预测模型:一项全国性队列研究
该回顾性全国性以色列队列研究利用Clalit健康保险数据库473 124名个体,纳入301 385例高尿酸血症患者,开发XGBoost机器学习模型预测痛风风险;模型ROC-AUC为0.781(95%CI 0.78-0.784),精确率-召回率AUC为0.208(95%CI 0.195-0.22),仅用五个变量的精简模型ROC-AUC为0.714(95%CI 0.706-0.723),阴性预测值为95%。
要点
- 在301 385例高尿酸血症患者中,15 055例(5%)被诊断为痛风。
- XGBoost模型ROC-AUC为0.781(95%CI 0.78-0.784),精确率-召回率AUC为0.208(95%CI 0.195-0.22)。
- 仅用血清尿酸、年龄、高脂血症、非甾体抗炎药和利尿剂五个变量的精简模型ROC-AUC为0.714(95%CI 0.706-0.723),阴性预测值为95%。
核心结论
- 该队列研究提示,基于机器学习的预测模型在识别高尿酸血症患者痛风风险方面具有相对良好的性能和较高的阴性预测值。
研究设计与样本
- 回顾性全国性以色列队列研究,使用Clalit健康保险数据库473 124名个体,纳入18岁及以上、2007年1月至2022年12月间至少两次血清尿酸测量超过6.8 mg/dl的成人,排除既往痛风诊断或使用痛风药物者,最终分析301 385例高尿酸血症患者。
主要发现
- 在301 385例高尿酸血症参与者中,15 055例(5%)被诊断为痛风。
- XGBoost模型ROC-AUC为0.781(95%CI 0.78-0.784),精确率-召回率AUC为0.208(95%CI 0.195-0.22)。
- 与痛风诊断最相关的变量为血清尿酸水平、年龄、高脂血症、非甾体抗炎药和利尿剂购买记录。
- 仅使用上述五个变量的精简模型ROC-AUC为0.714(95%CI 0.706-0.723),阴性预测值为95%。
关键数值与推荐
- 高尿酸血症定义为至少两次血清尿酸测量超过6.8 mg/dl。
- 主要结局为高尿酸血症患者中痛风诊断。
- 模型性能评估采用受试者工作特征曲线下面积(ROC-AUC)和精确率-召回率AUC。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop a machine learning-based prediction model for identifying hyperuricemic participants at risk of developing gout. METHODS: A retrospective nationwide Israeli cohort study used the Clalit Health Insurance database of 473 124 individuals to identify adults 18 years or older with at least two serum urate measurements exceeding 6.8 mg/dl between January 2007 and December 2022. Patients with a prior gout diagnosis or on gout medications were excluded. Patients' demographic characteristics, community and hospital diagnoses, routine medication prescriptions and laboratory results were used to train a risk prediction model. A machine learning model, XGBoost, was developed to predict the risk of gout. Feature selection methods were used to identify relevant variables. The model's performance was evaluated using the receiver operating characteristic area under the curve (ROC AUC) and precision-recall AUC. The primary outcome was the diagnosis of gout among hyperuricemic patients. RESULTS: Among the 301 385 participants with hyperuricemia included in the analysis, 15 055 (5%) were diagnosed with gout. The XGBoost model had a ROC-AUC of 0.781 (95% CI 0.78-0.784) and precision-recall AUC of 0.208 (95% CI 0.195-0.22). The most significant variables associated with gout diagnosis were serum uric acid levels, age, hyperlipidemia, non-steroidal anti-inflammatory drugs and diuretic purchases. A compact model using only these five variables yielded a ROC-AUC of 0.714 (95% CI 0.706-0.723) and a negative predictive value (NPV) of 95%. CONCLUSIONS: The findings of this cohort study suggest that a machine learning-based prediction model had relatively good performance and high NPV for identifying hyperuricemic participants at risk of developing gout.
引用
- Brikman S, Serfaty L, Abuhasira R, et al. A machine learning-based prediction model for gout in hyperuricemics: a nationwide cohort study. Rheumatology (Oxford). 2024. PMID: 38895877. doi:10.1093/rheumatology/keae273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。